Source: Annual Congress 2001 - Analyses of airway secretions, biopsies and serum in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. A. Groneberg, P. R. Eynott, T. Oates, R. Wu, I. Carlstedt, A. G. Nicholson, K. F. Chung (Berlin, Germany; London, United Kingdom; Davis, United States Of America; Lund, Sweden). Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Eur Respir J 2001; 16: Suppl. 31, 2527

Member's Comments

No comment yet.

Related content which might interest you: Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004 Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Source: Eur Respir J 2002; 19: 846-852 Year: 2002 Atypical respiratory pathogens in severe COPD exacerbations Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Severe asthma Source: ISSN=ISSN 1810-6838, ISBN=, page=128 Year: 2006 Severe asthma Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD Year: 2014 Severe asthma Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Severe asthma Source: ERS Lung Science Conference 2016 Year: 2016 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Role of respiratory infection in exacerbations of atopic asthma Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 The bronchial expression of vanin in moderate to severe asthma Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Bronchial asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study Source: Eur Respir J 2004; 24: Suppl. 48, 260s Year: 2004 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Treatment of bronchial asthma and wheezing disorders: acute Source: ERS Skills Course 2016 Year: 2016 Relationship between the severity of dyspnea and pulmonary function in acute COPD exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 251s Year: 2002 How persistent is ²persistent airflow limitation² in severe asthma? Source: Eur Respir J 2006; 28: Suppl. 50, 438s Year: 2006 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Comorbidities in severe asthma Source: International Congress 2019 – State of the art session: Airway disease Year: 2019